{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:03:45Z","timestamp":1785441825867,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018918","name":"MicroPort","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.hlc.2020.08.027","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:29:43Z","timestamp":1604150983000},"page":"707-713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of Anticoagulation Use in Indigenous and Non-Indigenous Australians With Atrial Fibrillation"],"prefix":"10.1016","volume":"30","author":[{"given":"Simon","family":"Rocheleau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5114-400X","authenticated-orcid":false,"given":"Celine","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley M.","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-1978","authenticated-orcid":false,"given":"Samuel J.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hanna-Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt C.","family":"Roberts-Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher X.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2020.08.027_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1071\/AH12186","article-title":"Does Australia have the appropriate health reform agenda to close the gap in Indigenous health?","volume":"37","author":"Donato","year":"2013","journal-title":"Aust Health Rev."},{"key":"10.1016\/j.hlc.2020.08.027_bib2","first-page":"2","article-title":"Chronic diseases and mortality in Canadian Aboriginal peoples: learning from the knowledge","volume":"31","author":"King","year":"2010","journal-title":"Chron Dis Can."},{"key":"10.1016\/j.hlc.2020.08.027_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(09)60914-4","article-title":"Indigenous health part 1: determinants and disease patterns","volume":"374","author":"Gracey","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.hlc.2020.08.027_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(16)00345-7","article-title":"Indigenous and tribal peoples' health (The Lancet-Lowitja Institute Global Collaboration): a population study","volume":"388","author":"Anderson","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.hlc.2020.08.027_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.hlc.2017.05.120","article-title":"Epidemiology of atrial fibrillation: the Australian and Asia-Pacific perspective","volume":"26","author":"Wong","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2020.08.027_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hlc.2020.08.027_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","article-title":"Epidemiology and natural history of atrial fibrillation: clinical implications","volume":"37","author":"Chugh","year":"2001","journal-title":"J\u00a0Am Coll Cardiol."},{"key":"10.1016\/j.hlc.2020.08.027_bib8","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.hlc.2018.03.024","article-title":"Oral anticoagulation therapy in atrial fibrillation patients managed in the emergency department compared to cardiology outpatient: opportunities for improved outcomes","volume":"28","author":"Rangnekar","year":"2019","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.hlc.2020.08.027_bib9","first-page":"10","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"352","author":"Emdin","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.hlc.2020.08.027_bib10","first-page":"11","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.hlc.2020.08.027_bib11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/heartjnl-2018-314471","article-title":"Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013","volume":"105","author":"Gallagher","year":"2019","journal-title":"Heart."},{"key":"10.1016\/j.hlc.2020.08.027_bib12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death. the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.hlc.2020.08.027_bib13","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.hlc.2020.08.027_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke."},{"key":"10.1016\/j.hlc.2020.08.027_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.clinthera.2014.08.002","article-title":"Management of Recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies","volume":"36","author":"Lau","year":"2014","journal-title":"Clin Ther."},{"key":"10.1016\/j.hlc.2020.08.027_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmjopen-2014-006242","article-title":"Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study","volume":"4","author":"Wong","year":"2014","journal-title":"BMJ Open."},{"key":"10.1016\/j.hlc.2020.08.027_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.pone.0121779","article-title":"Cardiovascular disease rates, outcomes, and quality of care in Ontario Metis: a population-based cohort study","volume":"10","author":"Atzema","year":"2015","journal-title":"PloS One."},{"key":"10.1016\/j.hlc.2020.08.027_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12872-015-0081-6","article-title":"Atrial fibrillation in the Indigenous populations of Australia, Canada, New Zealand, and the United States: a systematic scoping review","volume":"15","author":"Katzenellenbogen","year":"2015","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.hlc.2020.08.027_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijcard.2017.11.045","article-title":"Identification, risk assessment, and management of patients with atrial fibrillation in a large primary care cohort","volume":"254","author":"Poppe","year":"2018","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.hlc.2020.08.027_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/heartjnl-2014-306678","article-title":"Initial hospitalisation for atrial fibrillation in Aboriginal and non-Aboriginal populations in Western Australia","volume":"101","author":"Katzenellenbogen","year":"2015","journal-title":"Heart."},{"key":"10.1016\/j.hlc.2020.08.027_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.hlc.2020.08.027_bib22","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hlc.2020.08.027_bib23","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.hlc.2020.08.027_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/1755-5922.12129","article-title":"Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation","volume":"33","author":"Steinberg","year":"2015","journal-title":"Cardiovasc Ther."},{"key":"10.1016\/j.hlc.2020.08.027_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD Registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PloS One."},{"key":"10.1016\/j.hlc.2020.08.027_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.03.064","article-title":"Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians","volume":"191","author":"Wong","year":"2015","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.hlc.2020.08.027_bib27","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.hlc.2020.08.027_bib28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/STROKEAHA.110.601799","article-title":"Burden of stroke in Indigenous Western Australians. A study using data linkage","volume":"42","author":"Katzenellenbogen","year":"2011","journal-title":"Stroke."},{"key":"10.1016\/j.hlc.2020.08.027_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-4949.2007.00090.x","article-title":"Aboriginal and Torres strait islander peoples and the burden of stroke","volume":"2","author":"Thrift","year":"2007","journal-title":"Int J Stroke."},{"key":"10.1016\/j.hlc.2020.08.027_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review","volume":"40","author":"Pugh","year":"2011","journal-title":"Age Ageing."},{"key":"10.1016\/j.hlc.2020.08.027_bib31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Inter Med."},{"key":"10.1016\/j.hlc.2020.08.027_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jvs.2012.11.053","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"57","author":"Donze","year":"2013","journal-title":"J\u00a0Vasc Surg."},{"key":"10.1016\/j.hlc.2020.08.027_bib33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2006.10.047","article-title":"Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe - A report from the Euro Heart Survey on Atrial Fibrillation","volume":"49","author":"Dagres","year":"2007","journal-title":"J\u00a0Am Coll Cardiol."},{"key":"10.1016\/j.hlc.2020.08.027_bib34","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.hlc.2020.08.027_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.hlc.2020.08.027_bib36","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620314098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620314098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:04:11Z","timestamp":1761415451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950620314098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1443950620314098"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2020.08.027","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Anticoagulation Use in Indigenous and Non-Indigenous Australians With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2020.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}